U.S. Department of Health & Human Services
National Institutes of Health
NCATS
This repository is under review for potential modification in compliance with Administration directives.
Dismiss
Return Home
Inxight
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
Downloads
About
Search Substances
NARATUXIMAB EMTANSINE
WE1X5A83B9
Investigational
General
Names
8
Classification
1
Identifiers
6
Subunits
4
Related Substances
1
NARATUXIMAB EMTANSINE
WE1X5A83B9
Investigational
General
Approval Year
Unknown
149,124
Names
8
Show
5
20
100
All
entries
Name
Type
Language
Name
Type
Language
naratuximab emtansine [INN]
Preferred Name
English
NARATUXIMAB EMTANSINE
Official Name
English
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENSCD37 (TETRASPANIN-26, TSPAN26)), CHIMERIC MONOCLONAL ANTIBODY CONJUGATED TO MAYTANSINOID DM1
Common Name
English
DEBIO-1562
Code
English
Naratuximab emtansine [WHO-DD]
Common Name
English
Showing 1 to 5 of 8 entries
Previous
1
2
Next
Classification
1
Show
5
20
100
All
entries
Classification Tree
Code System
Code
Classification Tree
Code System
Code
Designated/Withdrawn
ORPHAN DRUG
Designated/Withdrawn
Treatment of diffuse large B-cell lymphoma
FDA ORPHAN DRUG
518016
Showing 1 to 1 of 1 entries
Previous
1
Next
Identifiers
6
Show
5
20
100
All
entries
Code System
Code
Type
Description
Code System
Code
Type
Description
SMS_ID
100000177044
PRIMARY
INN
10238
PRIMARY
CAS
1607824-64-5
PRIMARY
DRUG BANK
DB15453
PRIMARY
NCI_THESAURUS
C100101
PRIMARY
Showing 1 to 5 of 6 entries
Previous
1
2
Next
Subunits
4
Subunit 0
>SUBUNIT_0
Subunit 1
>SUBUNIT_1
Subunit 2
>SUBUNIT_2
Subunit 3
>SUBUNIT_3
Related Substances
1
ACTIVE MOIETY
WE1X5A83B9
NARATUXIMAB EMTANSINE